Botanix Pharmaceuticals Limited has released a press release.
S&P DJI Announces September 2026 Quarterly Rebalance
Earlier from Botanix Pharmaceuticals
- Appendix 4E & Annual Report for the Year Ended 30 June 2026
- Botanix Quarterly Activities Report and Appendix 4C Q4 FY26
- Notice of Allowance for US patent on Sofdra drug substance
- Intention to Grant a European patent on Sofdra applicator